RxDoctor Payments Data

Charles Carim, PA

Physician Assistant · Greensboro, NCNPI 1497461289

Payments from drug & device makers

$1,118in general payments, 2019–2025

Across 47 payments — averaging $23.79 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$261
  • Sumitomo Pharma America, Inc.$214
  • Urogen Pharma, Inc.$137
  • Argon Medical Devices, Inc.$120
  • Bayer$102
  • Novartis$85
  • plus $198 from 5 others

What the payments were for

  • Food & beverage$1,118100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,118 in reported general payments places this provider in the 70th percentile of 7,441 physician assistant providers in North Carolina.

See all physician assistant providers in North Carolina

Medicare billing

Part B allowed, 2024
$35,450
Medicare patients
222
Services billed
1,317

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MyrbetriqMirabegron49$30,575
GemtesaVibegron26$14,477
Tamsulosin Hcl202$2,398
Finasteride96$1,193
Silodosin22$1,145
Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst48$1,086
Estradiol11$604
Cephalexin82$598
Doxycycline Hyclate58$586
Ciprofloxacin Hcl65$462
NitrofurantoinNitrofurantoin Macrocrystal12$411
Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip17$280
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim40$206
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav12$155
Fluconazole26$126

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Sumitomo Pharma America, Inc.Gemtesa$214$14,47726 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 7,441 physician assistant providers in North Carolina.

Other physician assistant in Greensboro

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →